TerrAscend closes $13M option to buy 35% of Union Chill NJ dispensary; accretive to EBITDA

TerrAscend Corp.

Total consideration $13M: $9M convertible notes (6.5%, due 2029) plus $4M cash on option exercise.
Union Chill generates >$11M annualized revenue; expected immediately accretive to EBITDA and cashflow.
Expands NJ retail to four dispensaries; upon full exercise, total consolidated footprint reaches 20.
Notes convertible at $1.89/share, only in entirety; prepayment allowed in $50K increments with 30-day notice.

item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.